Association Between First- and Third-Month Responses to Intravitreal Ranibizumab for Diabetic Macular Edema.
J Vitreoretin Dis
; 5(2): 99-107, 2021.
Article
in En
| MEDLINE
| ID: mdl-37009080
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
J Vitreoretin Dis
Year:
2021
Document type:
Article